2020 was like no other year. Medical device companies and their employees had to quickly scale up production to meet demand for urgently needed medical supplies while finding new ways to work safely during a pandemic.

Such shifts occurred while manufacturing in general was in the midst of a significant digital transformation—some may call it Industry 4.0, smart manufacturing, or even the rise of big data. Some medtech companies had already begun automating the collection of data throughout their operations for analysis and continuous improvement, among other initiatives. Many, though, had still been waiting and watching, perhaps not sure of the necessity or even the right strategy. But telecommuting, social distancing, and just-in-time fulfillment demonstrated the need for better data visibility and data-driven decision-making.

SPR Therapeutics Inc., a manufacturer of a minimally invasive neuromodulation implantable for pain called Sprint, had its own transformation well underway when the pandemic struck. It had already replaced siloed antiquated data management systems and was automating its data-handling processes end to end with a Salesforce platform implemented by Rootstock, ComplianceQuest, and CloudLoop.

Ben Austin, chief financial officer for SPR Therapeutics, explores how this solution helped manage disruptions during the pandemic in the now on-demand webinar, “Medical Device Manufacturing: After Surviving 2020, Win in 2021.” He is joined by David Stephans, president of Rootstock Software; Prashanth Rajendran, chief executive officer of ComplianceQuest; Travis Buckley, vice president, commercial sales - Healthcare and Life Science
Salesforce.com; and Hussein Kermally, chief executive officer, CloudLoop. These experts discuss digital transformation and more in a virtual roundtable discussion.

Austin says that before implementation, the company spent a lot of time talking about data sources and whether data matched up rather than focusing on learning from that data. Thanks to the platform, SPR Therapeutics has moved away from situations in which it was solely dependent on individual employees for data. And when COVID hit, Austin and his team were able to dig into the data in a matter of days to have real discussions about what COVID meant for its business.

And beyond the pandemic, SPR Therapeutics's employees—from management to engineering teams—now have real-time platform capabilities that enable faster response to customer and market needs.

Join us for a lively discussion on SPR Therapeutics’s transformation as well as potential gains for medtech companies. The webinar should be of particular interest to CXOs, VPs, and Directors of IT, Technology, Compliance, Quality, Supply Chain, Operations, Manufacturing, Finance, Product Development, and Engineering.

The speakers aim to share insights on: